3,000 Shares in Inspire Medical Systems, Inc. (NYSE:INSP) Purchased by Hodges Capital Management Inc.

Hodges Capital Management Inc. purchased a new position in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 3,000 shares of the company's stock, valued at approximately $633,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. AQR Capital Management LLC grew its stake in Inspire Medical Systems by 152.7% in the 2nd quarter. AQR Capital Management LLC now owns 231,845 shares of the company's stock worth $31,028,000 after buying an additional 140,090 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of Inspire Medical Systems in the 3rd quarter valued at $1,929,000. SG Americas Securities LLC boosted its stake in shares of Inspire Medical Systems by 114.2% in the 2nd quarter. SG Americas Securities LLC now owns 6,228 shares of the company's stock valued at $833,000 after purchasing an additional 3,321 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in shares of Inspire Medical Systems by 39.7% in the 3rd quarter. Thrivent Financial for Lutherans now owns 110,580 shares of the company's stock valued at $23,337,000 after purchasing an additional 31,444 shares in the last quarter. Finally, Headlands Technologies LLC purchased a new stake in shares of Inspire Medical Systems in the 2nd quarter valued at $1,391,000. Hedge funds and other institutional investors own 94.91% of the company's stock.

Inspire Medical Systems Trading Down 1.8 %

NYSE INSP traded down $3.51 during trading on Monday, hitting $189.52. The company had a trading volume of 227,312 shares, compared to its average volume of 589,395. Inspire Medical Systems, Inc. has a one year low of $123.00 and a one year high of $257.40. The company has a market cap of $5.68 billion, a price-to-earnings ratio of 177.12 and a beta of 1.31. The company's fifty day moving average is $195.93 and its 200-day moving average is $177.95.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last issued its quarterly earnings data on Monday, November 4th. The company reported $0.60 EPS for the quarter, topping the consensus estimate of $0.06 by $0.54. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The business had revenue of $203.20 million during the quarter, compared to analyst estimates of $197.59 million. During the same period in the prior year, the business earned ($0.29) EPS. The company's revenue for the quarter was up 32.6% on a year-over-year basis. As a group, equities analysts anticipate that Inspire Medical Systems, Inc. will post 1.33 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on INSP. Bank of America raised shares of Inspire Medical Systems from a "neutral" rating to a "buy" rating and upped their price objective for the company from $220.00 to $255.00 in a research note on Wednesday, November 20th. Truist Financial reaffirmed a "buy" rating and issued a $240.00 price objective (up previously from $217.00) on shares of Inspire Medical Systems in a research note on Monday, September 30th. Stifel Nicolaus reaffirmed a "hold" rating and issued a $200.00 price objective (up previously from $170.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Robert W. Baird upped their price target on shares of Inspire Medical Systems from $240.00 to $252.00 and gave the company an "outperform" rating in a report on Tuesday, November 5th. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $260.00 price target on shares of Inspire Medical Systems in a report on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company's stock. According to data from MarketBeat.com, Inspire Medical Systems has an average rating of "Moderate Buy" and an average target price of $233.58.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.